标题
Telaprevir
作者
关键词
-
出版物
DRUGS
Volume 72, Issue 5, Pages 619-641
出版商
Springer Nature
发表日期
2012-03-24
DOI
10.2165/11208370-000000000-00000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients
- (2012) P. Ramachandran et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Treatment failure with new hepatitis C drugs
- (2012) Vincent Soriano et al. EXPERT OPINION ON PHARMACOTHERAPY
- Challenges and opportunities for hepatitis C drug development in HIV–hepatitis C virus-co-infected patients
- (2011) Vincent Soriano et al. AIDS
- Effect of the Hepatitis C Virus Protease Inhibitor Telaprevir on the Pharmacokinetics of Amlodipine and Atorvastatin
- (2011) Jee Eun Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Drugs in Development for Viral Hepatitis
- (2011) Paul J. Pockros DRUGS
- Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections
- (2011) Graham R. Foster et al. GASTROENTEROLOGY
- Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus
- (2011) Varun Garg et al. HEPATOLOGY
- Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents - A potentially lethal cocktail
- (2011) Michael Charlton HEPATOLOGY
- Genotype differences in susceptibility and resistance development of hepatitis C virus to protease inhibitors telaprevir (VX-950) and danoprevir (ITMN-191)
- (2011) Ingrid Imhof et al. HEPATOLOGY
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2011) JOURNAL OF HEPATOLOGY
- Dermatological side effects of hepatitis C and its treatment: Patient management in the era of direct-acting antivirals
- (2011) Patrice Cacoub et al. JOURNAL OF HEPATOLOGY
- Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?
- (2011) Mitchell L. Shiffman et al. LIVER INTERNATIONAL
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Directly acting antivirals for hepatitis C and antiretrovirals
- (2011) Kay Seden et al. Current Opinion in HIV and AIDS
- Characterization of V36C, a Novel Amino Acid Substitution Conferring Hepatitis C Virus (HCV) Resistance to Telaprevir, a Potent Peptidomimetic Inhibitor of HCV Protease
- (2010) L. Barbotte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors
- (2010) A. Bae et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C
- (2010) Patrick Marcellin et al. GASTROENTEROLOGY
- Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin
- (2010) Norio Akuta et al. HEPATOLOGY
- Telaprevir for Previously Treated Chronic HCV Infection
- (2010) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- GT-1a or GT-1b Subtype-Specific Resistance Profiles for Hepatitis C Virus Inhibitors Telaprevir and HCV-796
- (2009) M. F. McCown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
- (2009) Gary L. Davis et al. GASTROENTEROLOGY
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
- (2009) Christophe Hézode et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review: Therapeutic implications of hepatitis C virus resistance to antiviral drugs
- (2009) Jean-Michel Pawlotsky Therapeutic Advances in Gastroenterology
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
- Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus
- (2008) Christoph Welsch et al. GENOME BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started